SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEbiquity Regulatory News (EBQ)

Share Price Information for Ebiquity (EBQ)

Share Price is delayed by 15 minutes
Get Live Data
10.75    0.00 (0.00%)
Bid:
10.50
Ask:
11.00
Spread: 0.50 (4.762%)
Market Cap: £14.94m
EBQ Live PriceLast checked at - London Stock Exchange

Intraday Ebiquity Share Chart

DIRECTORS’ DEALING

15 Mar 2024 10:35

RNS Number : 0602H
Ebiquity PLC
15 March 2024
Β 

15 March 2024

Β 

Β 

Ebiquity Plc

("the Company" or "Ebiquity")

Β 

DIRECTORS' DEALING

Β 

The Company announces that Nick Waters, Chief Executive Officer, was granted an award over 1,094,288 ordinary shares of 25p each in the Company ("Ordinary Shares") under the Company's share option plan yesterday. Julia Hubbard, Chief Financial Officer was also granted an award yesterday over 481,844 Ordinary Shares under the same plan. These awards are in the form of nil priced options. They were granted in relation to FY 2023 and are subject to a performance target based on earnings per share being met at the end of the three year period to 31 December 2025.

Β 

The notifications below, made in accordance with the requirements of the UK Market Abuse Regulation, provide further detail in respect of the transactions described above.Β 

Β 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Nick Waters

2.

Reason for the notification

a)

Position/status:

Chief Executive Officer

b)

Initial notification/Amendment:

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

Ebiquity plc

b)

LEI:

2138004YRTDJ7FJSWF20

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument? (ii) each type of transaction? (iii) each date? and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument: Identification code:

Ordinary Shares of 25p each

GB0004126057

b)

Nature of the transaction:

Grant of share option award

c)

Price(s) and volume(s):

Price(s)

Volume(s)

nil

1,094,288

d)

Aggregated information:

Β· Aggregated volume:

Β· Price:

Single transaction as in 4 c) above

1,094,288

nil

e)

Date of the transaction:

2024-03-14

f)

Place of the transaction:

Outside of a trading venue

Β 

Β 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Julia Hubbard

2.

Reason for the notification

a)

Position/status:

Chief Financial Officer

b)

Initial notification/Amendment:

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

Ebiquity plc

b)

LEI:

2138004YRTDJ7FJSWF20

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument? (ii) each type of transaction? (iii) each date? and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument: Identification code:

Ordinary Shares of 25p each

GB0004126057

b)

Nature of the transaction:

Grant of share option award

c)

Price(s) and volume(s):

Price(s)

Volume(s)

nil

481,844

d)

Aggregated information:

Β· Aggregated volume:

Β· Price:

Single transaction as in 4 c) above

481,844

nil

e)

Date of the transaction:

2024-03-14

f)

Place of the transaction:

Outside of a trading venue

Β 

Enquiries:

Β 

Ebiquity plc

Nick Waters (CEO)

Julia Hubbard (CFO)

Lorraine Young (Company Secretary)

Β 

+44 (0) 20 7650 9600

Β 

Camarcco

Ben Woodford

Geoffrey Pelham-Lane

+44 (0) 7990 653 341

+44 (0) 7733 124 226

Β 

Panmure Gordon (Financial Adviser, NOMAD & Broker)

Dominic Morley / Dougie McLeod (Corporate Advisory)

Mark Murphy / Sam Elder (Corporate Broking)

Β 

+44 (0) 20 7886 2500

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHUVORRSSUOAAR
Date   Source Headline
11th Mar 20152:16 pmRNSExercise of Share Options
26th Feb 20152:14 pmRNSAcquisition of Media Value
16th Feb 201512:45 pmRNSExercise of Share Options
13th Feb 20153:50 pmRNSAcquisition and issue of shares
6th Feb 201510:34 amRNSDirector/PDMR Shareholding
4th Feb 20155:00 pmRNSHolding(s) in Company
2nd Feb 20152:55 pmRNSHolding(s) in Company
28th Jan 20157:00 amRNSInterim Results
19th Jan 20158:45 amRNSExercise of Share Options
8th Jan 20154:28 pmRNSHolding(s) in Company
27th Nov 20147:00 amRNSExercise of Share Options
24th Nov 20143:00 pmRNSDirector Dealing
24th Nov 20142:59 pmRNSHolding(s) in Company
24th Nov 20142:55 pmRNSDirector Dealing and Exercise of Share Options
21st Nov 20147:00 amRNSAppointment of Non-Executive Directors
21st Nov 20147:00 amRNSTrading update
14th Nov 20143:22 pmRNSDirector Dealing
11th Nov 20149:10 amRNSDirector Dealing
10th Sep 201411:57 amRNSResult of AGM
6th Aug 20147:00 amRNSAnnual Report
31st Jul 20143:49 pmRNSHolding(s) in Company
16th Jul 20147:00 amRNSFinal Results
3rd Jul 20147:00 amRNSNew Debt Facility
13th Jun 20148:30 amRNSAppointment of MD, South East Asia
16th May 201411:33 amRNSAward of share options
8th May 20147:00 amRNSAcquisition
14th Apr 20147:00 amRNSAppointment of CEO, Americas
7th Apr 20147:00 amRNSPayment of deferred consideration
19th Mar 20147:00 amRNSChange of Registered Office
13th Mar 20143:05 pmRNSHolding(s) in Company
11th Mar 20145:32 pmRNSExercise of Share Options
7th Mar 20141:04 pmRNSExercise of Share Options
7th Mar 20147:00 amRNSDirectors' dealings and directorate changes
6th Mar 20147:00 amRNSDirectorate
3rd Mar 201412:02 pmRNSHolding(s) in Company
21st Feb 20149:32 amRNSHolding(s) in Company
20th Feb 20145:45 pmRNSHolding in Company / Issue of Equity
13th Feb 201411:00 amRNSHolding in Company / Issue of Equity
13th Feb 201410:24 amRNSHolding(s) in Company
12th Feb 201410:34 amRNSHolding(s) in Company
7th Feb 201412:50 pmRNSHolding(s) in Company
7th Feb 201412:10 pmRNSHolding(s) in Company
6th Feb 201412:02 pmRNSHolding(s) in Company
5th Feb 20144:49 pmRNSHolding(s) in Company
22nd Jan 20145:34 pmRNSExercise of Share Options
21st Jan 20144:06 pmRNSExercise of Share Options
17th Jan 20144:24 pmRNSDirector/PDMR Shareholding
15th Jan 20147:00 amRNSInterim Results
15th Jan 20147:00 amRNSAcquisition
15th Jan 20147:00 amRNSConclusion of Review of Strategic Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.